Candel Therapeutics to Present CAN-2409 Data at SITC 2025

Candel Therapeutics will present data from its enLIGHTEN™ Discovery Platform and CAN-2409 program in non-small cell lung cancer (NSCLC) at the SITC 20...
Home/KnloSights/Clinical Trial Updates/Candel Therapeutics to Present CAN-2409 Data at SITC 2025